DK1489090T3 - Hidtil ukendte pseudoerythromycinderivater - Google Patents

Hidtil ukendte pseudoerythromycinderivater

Info

Publication number
DK1489090T3
DK1489090T3 DK04022619T DK04022619T DK1489090T3 DK 1489090 T3 DK1489090 T3 DK 1489090T3 DK 04022619 T DK04022619 T DK 04022619T DK 04022619 T DK04022619 T DK 04022619T DK 1489090 T3 DK1489090 T3 DK 1489090T3
Authority
DK
Denmark
Prior art keywords
hitherto unknown
derivatives
pseudoerythromycin
pseudoerythromycin derivatives
psedoerythromycin
Prior art date
Application number
DK04022619T
Other languages
English (en)
Inventor
Satoshi Omura
Yuzuru Iwai
Toshiaki Sunazuka
Tohru Nagamitsu
Original Assignee
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst filed Critical Kitasato Inst
Application granted granted Critical
Publication of DK1489090T3 publication Critical patent/DK1489090T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK04022619T 2000-08-17 2000-08-17 Hidtil ukendte pseudoerythromycinderivater DK1489090T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2000/005503 WO2002014338A1 (fr) 2000-08-17 2000-08-17 Nouveaux derives de pseudoerythromycine
EP00953461A EP1256587B1 (en) 2000-08-17 2000-08-17 Novel pseudoerythromycin derivatives

Publications (1)

Publication Number Publication Date
DK1489090T3 true DK1489090T3 (da) 2006-05-22

Family

ID=11736361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04022619T DK1489090T3 (da) 2000-08-17 2000-08-17 Hidtil ukendte pseudoerythromycinderivater

Country Status (11)

Country Link
US (1) US6734292B1 (da)
EP (2) EP1489090B1 (da)
KR (6) KR20040066186A (da)
AT (2) ATE316977T1 (da)
AU (1) AU2000265939A1 (da)
CA (1) CA2386828C (da)
DE (2) DE60025856T2 (da)
DK (1) DK1489090T3 (da)
ES (2) ES2261224T3 (da)
PT (1) PT1489090E (da)
WO (1) WO2002014338A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7351834B1 (en) 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
CA2359244C (en) 1999-01-13 2013-10-08 Bayer Healthcare Llc .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US20030216396A1 (en) 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
EP2324825A1 (en) 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
JP2003327536A (ja) * 2002-03-07 2003-11-19 Kitasato Inst:The ヒト免疫不全症候群ウイルスの感染、増殖抑制剤
US20040067896A1 (en) * 2002-07-25 2004-04-08 The Kitasato Institute Novel pseudoerythromycin derivatives
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
DE602004007382T2 (de) 2003-05-20 2008-04-17 Bayer Pharmaceuticals Corp., West Haven Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
DK1663978T3 (da) 2003-07-23 2008-04-07 Bayer Pharmaceuticals Corp Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
US7419962B2 (en) * 2004-12-07 2008-09-02 Enanta Pharmaceuticals, Inc. 3,6-bicyclolides
US7229972B2 (en) * 2004-12-07 2007-06-12 Enanta Pharmaceuticals, Inc. 3,6-Bicyclolides
JP2009506066A (ja) 2005-08-24 2009-02-12 リブ−エックス ファーマシューティカルズ,インコーポレイテッド トリアゾール化合物ならびにこれを作製する方法および使用する方法
PL1950219T3 (pl) * 2005-10-14 2011-11-30 The Kitasato Inst Nowe pochodne dihydropseudoerytromycyny
US7407942B2 (en) * 2006-03-29 2008-08-05 Emata Pharmaceuticals, Inc 3,6-bridged 9,12-oxolides
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US20090098527A1 (en) * 2006-09-12 2009-04-16 Fischer Gerald W Biological organism identification product and methods
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
EP3058954B1 (en) * 2007-08-27 2017-03-01 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
DK2195466T3 (da) * 2007-10-01 2013-01-14 Longhorn Vaccines & Diagnostics Llc Fremgangsmåde til opbevaring af biologiske prøver
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
JP5733601B2 (ja) * 2010-07-13 2015-06-10 国立大学法人 千葉大学 劇症型炎症の予防および/または治療剤
WO2013112916A1 (en) 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US9976136B2 (en) 2015-05-14 2018-05-22 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
MX2024002892A (es) * 2021-09-07 2024-04-05 Zoetis Services Llc Azalidos inmunomoduladores.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106961A (en) 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
CA1321581C (en) 1987-05-26 1993-08-24 Herbert A. Kirst Ring-contracted macrolides
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
US5554605A (en) 1991-04-09 1996-09-10 Abbott Laboratories Macrocyclic lactam prokinetic agents
ATE139697T1 (de) 1991-04-09 1996-07-15 Abbott Lab Macrozyklische laktam-prokinetika
DE4200145A1 (de) 1992-01-07 1993-07-08 Kali Chemie Pharma Gmbh 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE19644195A1 (de) 1996-10-24 1998-04-30 Solvay Pharm Gmbh 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19805822B4 (de) 1998-02-13 2009-02-05 Solvay Pharmaceuticals Gmbh 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
US6734292B1 (en) 2004-05-11
DE60027015T2 (de) 2006-10-05
EP1489090A1 (en) 2004-12-22
EP1256587A4 (en) 2004-01-28
ATE316977T1 (de) 2006-02-15
KR20040066187A (ko) 2004-07-23
KR20040066186A (ko) 2004-07-23
PT1489090E (pt) 2006-05-31
DE60025856D1 (de) 2006-04-13
EP1256587A1 (en) 2002-11-13
WO2002014338A1 (fr) 2002-02-21
CA2386828C (en) 2006-01-24
KR20040066185A (ko) 2004-07-23
CA2386828A1 (en) 2002-02-21
DE60027015D1 (en) 2006-05-18
EP1489090B1 (en) 2006-02-01
KR20040066184A (ko) 2004-07-23
EP1256587B1 (en) 2006-03-29
ATE321770T1 (de) 2006-04-15
ES2261224T3 (es) 2006-11-16
KR20040074096A (ko) 2004-08-21
DE60025856T2 (de) 2006-10-19
AU2000265939A1 (en) 2002-02-25
KR20040066188A (ko) 2004-07-23
ES2257720T3 (es) 2006-08-01

Similar Documents

Publication Publication Date Title
ATE321770T1 (de) Pseudoerythromycin-derivate
ECSP045294A (es) Derivados de 2,4-diaminopirimidina
EA200400893A1 (ru) N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств
UY26551A1 (es) " agentes antibacterianos de 3-aminoquinazolin-2,4,dionas".
ES2182234T3 (es) Inhibidores de metaloproteasa.
ES2088537T3 (es) Derivados de piranil cianoguanidina.
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
DK1295890T3 (da) Hidtil ukendte pyrazinderivater eller salte deraf, farmaceutiske præparater, der indeholder derivaterne eller saltene, og mellemprodukter til fremstilling af begge
CY1123488T1 (el) Πεντακυκλοθειενυλο και ινδανυλο παραγωγα ουριας ως παραγοντες διανοιξης διαυλου καλιου
AR024746A1 (es) Androgenos oralmente activos.
UY27338A1 (es) Nuevos derivados de ácido sulfónico
MA27046A1 (fr) Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens.
ATE278661T1 (de) Anthranilsäurederivate
EP1671957A4 (en) THIADIAZOLINDERIVATE
DK1454903T3 (da) Thiadiazolinderivater til behandling af cancer
CO5680420A2 (es) Compuestos de 6-amino-1h-indazol y 4-aminobenzenofurano como inhibidores de la fosfodiesterasa 4
BRPI0408675A (pt) derivados de talidomida solúveis em água
EA200400822A1 (ru) Производные 3,4-дигидро-1h-изохинолин-2-ила
DE60017374D1 (de) Antibakterielle mittel
EA200200838A1 (ru) N-(гетероциклил)бензол- или пиридинсульфонамиды в качестве антитромботических агентов и антикоагулянтов
CY1106446T1 (el) 5-υποκατεστημενα -αλκυλαμινοπυραζολικα παραγωγα ως παρασιτοκτονα
BR0113978A (pt) Derivados de tiazol de 2-metoxiimino-2-(piridiniloximetil)-fenil-acetamidas úteis como fungicidas
BR0110328A (pt) Compostos heterocìclicos com atividade antiinflamatória
BR0210749A (pt) Composições de fragrância e sabor
DE60230924D1 (de) 2-substituierte vitamin-d-derivate